Hangzhou AGS MedTech Co Ltd
SSE:688581
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Hangzhou AGS MedTech Co Ltd
Revenue
Hangzhou AGS MedTech Co Ltd
Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
H
|
Hangzhou AGS MedTech Co Ltd
SSE:688581
|
Revenue
¥636.6m
|
CAGR 3-Years
28%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
A
|
APT Medical Inc
SSE:688617
|
Revenue
¥2.6B
|
CAGR 3-Years
29%
|
CAGR 5-Years
40%
|
CAGR 10-Years
N/A
|
|
|
J
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
|
Revenue
¥7.9B
|
CAGR 3-Years
0%
|
CAGR 5-Years
2%
|
CAGR 10-Years
13%
|
|
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
Revenue
¥33.3B
|
CAGR 3-Years
3%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
|
|
Andon Health Co Ltd
SZSE:002432
|
Revenue
¥1.6B
|
CAGR 3-Years
-61%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
16%
|
|
|
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
|
Revenue
¥10.3B
|
CAGR 3-Years
12%
|
CAGR 5-Years
28%
|
CAGR 10-Years
N/A
|
|
Hangzhou AGS MedTech Co Ltd
Glance View
Hangzhou AGS MedTech Co., Ltd. engages in the research and development, manufacture, and sale of equipment in minimally invasive diagnosis and treat. The company is headquartered in Hangzhou, Zhejiang and currently employs 501 full-time employees. The company went IPO on 2023-05-19. The firm's main products are used in the field of digestive endoscopy diagnosis and treatment, and are divided into hemostatic closure, EMR/ESD, biopsy, ERCP and diagnosis and treatment instruments according to their therapeutic purposes. The hemostatic closure category includes clip devices and single-use bipolar high-frequency hemostats. Medical instruments include high-frequency surgical equipment, carbon dioxide gas supply devices for endoscopes, and water supply devices for endoscopes. The biopsy category includes single-use biopsy forceps and single-use graspers.
See Also
What is Hangzhou AGS MedTech Co Ltd's Revenue?
Revenue
636.6m
CNY
Based on the financial report for Dec 31, 2024, Hangzhou AGS MedTech Co Ltd's Revenue amounts to 636.6m CNY.
What is Hangzhou AGS MedTech Co Ltd's Revenue growth rate?
Revenue CAGR 3Y
28%
Over the last year, the Revenue growth was 25%. The average annual Revenue growth rates for Hangzhou AGS MedTech Co Ltd have been 28% over the past three years .
